

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | membrane repolarization (GO:0086009) | 9.95194265 |
| 2 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 8.89748540 |
| 3 | regulation of guanylate cyclase activity (GO:0031282) | 7.76398890 |
| 4 | ventricular cardiac muscle cell action potential (GO:0086005) | 7.36516318 |
| 5 | lipoprotein transport (GO:0042953) | 7.30560004 |
| 6 | regulation of heart rate by cardiac conduction (GO:0086091) | 7.26726583 |
| 7 | folic acid transport (GO:0015884) | 7.00732300 |
| 8 | regulation of membrane repolarization (GO:0060306) | 6.70788251 |
| 9 | epoxygenase P450 pathway (GO:0019373) | 6.70298675 |
| 10 | regulation of bile acid biosynthetic process (GO:0070857) | 6.68515592 |
| 11 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 6.36905141 |
| 12 | NADH metabolic process (GO:0006734) | 6.32224937 |
| 13 | positive regulation of guanylate cyclase activity (GO:0031284) | 6.29167086 |
| 14 | fat-soluble vitamin biosynthetic process (GO:0042362) | 6.21753502 |
| 15 | intestinal absorption (GO:0050892) | 6.14914534 |
| 16 | cardiac conduction (GO:0061337) | 6.01983929 |
| 17 | negative regulation of complement activation (GO:0045916) | 5.74213868 |
| 18 | phenylpropanoid metabolic process (GO:0009698) | 5.67172857 |
| 19 | omega-hydroxylase P450 pathway (GO:0097267) | 5.65093934 |
| 20 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 5.52399196 |
| 21 | endocrine process (GO:0050886) | 5.52399196 |
| 22 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 5.52399196 |
| 23 | regulation of cellular extravasation (GO:0002691) | 5.46332706 |
| 24 | hormone catabolic process (GO:0042447) | 5.40110152 |
| 25 | fructose metabolic process (GO:0006000) | 5.21515410 |
| 26 | regulation of cGMP biosynthetic process (GO:0030826) | 5.03078256 |
| 27 | prostate gland growth (GO:0060736) | 4.99939191 |
| 28 | drug metabolic process (GO:0017144) | 4.98892214 |
| 29 | retinol metabolic process (GO:0042572) | 4.98116147 |
| 30 | mitochondrion distribution (GO:0048311) | 4.97989243 |
| 31 | regulation of systemic arterial blood pressure (GO:0003073) | 4.95704969 |
| 32 | valine metabolic process (GO:0006573) | 4.94329000 |
| 33 | peptide hormone processing (GO:0016486) | 4.91550326 |
| 34 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 4.89284822 |
| 35 | regulation of potassium ion transmembrane transport (GO:1901379) | 4.88581104 |
| 36 | virion attachment to host cell (GO:0019062) | 4.86634761 |
| 37 | adhesion of symbiont to host cell (GO:0044650) | 4.86634761 |
| 38 | negative regulation of protein activation cascade (GO:2000258) | 4.82967915 |
| 39 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 4.75798545 |
| 40 | cardiac muscle cell action potential (GO:0086001) | 4.69623587 |
| 41 | digestion (GO:0007586) | 4.65694505 |
| 42 | cellular glucuronidation (GO:0052695) | 4.61790237 |
| 43 | glycerophospholipid catabolic process (GO:0046475) | 4.61457980 |
| 44 | glucuronate metabolic process (GO:0019585) | 4.58589237 |
| 45 | uronic acid metabolic process (GO:0006063) | 4.58589237 |
| 46 | regulation of triglyceride catabolic process (GO:0010896) | 4.52944894 |
| 47 | bile acid and bile salt transport (GO:0015721) | 4.50248423 |
| 48 | polyol transport (GO:0015791) | 4.49650919 |
| 49 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.43664458 |
| 50 | melanin metabolic process (GO:0006582) | 4.42970506 |
| 51 | detection of temperature stimulus (GO:0016048) | 4.42173035 |
| 52 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.37951278 |
| 53 | diacylglycerol metabolic process (GO:0046339) | 4.36062009 |
| 54 | melanin biosynthetic process (GO:0042438) | 4.35411243 |
| 55 | cellular copper ion homeostasis (GO:0006878) | 4.32696745 |
| 56 | regulation of cGMP metabolic process (GO:0030823) | 4.24100788 |
| 57 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 4.23528196 |
| 58 | multicellular organismal signaling (GO:0035637) | 4.15279809 |
| 59 | peptide catabolic process (GO:0043171) | 4.15058075 |
| 60 | urea cycle (GO:0000050) | 4.13270520 |
| 61 | tyrosine metabolic process (GO:0006570) | 4.12661301 |
| 62 | positive regulation of glycoprotein metabolic process (GO:1903020) | 4.08887383 |
| 63 | antibacterial humoral response (GO:0019731) | 4.07228287 |
| 64 | negative regulation of humoral immune response (GO:0002921) | 4.05944466 |
| 65 | xenobiotic catabolic process (GO:0042178) | 4.05545846 |
| 66 | drug catabolic process (GO:0042737) | 4.05074343 |
| 67 | alkaloid metabolic process (GO:0009820) | 4.00764721 |
| 68 | fat-soluble vitamin metabolic process (GO:0006775) | 3.98317586 |
| 69 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.97918785 |
| 70 | secondary metabolite biosynthetic process (GO:0044550) | 3.97056942 |
| 71 | homocysteine metabolic process (GO:0050667) | 3.96606368 |
| 72 | urea metabolic process (GO:0019627) | 3.95480520 |
| 73 | adhesion of symbiont to host (GO:0044406) | 3.94211692 |
| 74 | regulation of phospholipid biosynthetic process (GO:0071071) | 3.91274117 |
| 75 | glycolipid catabolic process (GO:0019377) | 3.90624915 |
| 76 | glycosphingolipid catabolic process (GO:0046479) | 3.87819528 |
| 77 | vitamin transmembrane transport (GO:0035461) | 3.86034509 |
| 78 | antimicrobial humoral response (GO:0019730) | 3.85277525 |
| 79 | drinking behavior (GO:0042756) | 3.84947250 |
| 80 | plasma lipoprotein particle assembly (GO:0034377) | 3.81133113 |
| 81 | cGMP biosynthetic process (GO:0006182) | 3.80192753 |
| 82 | exogenous drug catabolic process (GO:0042738) | 3.76166028 |
| 83 | cellular response to nitric oxide (GO:0071732) | 3.75219962 |
| 84 | arginine metabolic process (GO:0006525) | 3.73338114 |
| 85 | ventricular system development (GO:0021591) | 3.72049371 |
| 86 | renal system process involved in regulation of blood volume (GO:0001977) | 3.71037352 |
| 87 | transepithelial transport (GO:0070633) | 3.66387964 |
| 88 | lipoprotein metabolic process (GO:0042157) | 3.65669516 |
| 89 | cell volume homeostasis (GO:0006884) | 3.65481271 |
| 90 | nitrogen cycle metabolic process (GO:0071941) | 3.58377416 |
| 91 | ear development (GO:0043583) | 3.48217165 |
| 92 | mRNA modification (GO:0016556) | 3.48013111 |
| 93 | midgut development (GO:0007494) | 3.46569510 |
| 94 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 3.46511978 |
| 95 | regulation of vitamin metabolic process (GO:0030656) | 3.46164753 |
| 96 | neurotransmitter catabolic process (GO:0042135) | 3.45124632 |
| 97 | positive regulation of cGMP metabolic process (GO:0030825) | 3.43548293 |
| 98 | glomerulus development (GO:0032835) | 3.43145070 |
| 99 | hypotonic response (GO:0006971) | 3.41905385 |
| 100 | positive regulation of pseudopodium assembly (GO:0031274) | 3.41157942 |
| 101 | bile acid metabolic process (GO:0008206) | 3.40798984 |
| 102 | glycosylceramide metabolic process (GO:0006677) | 3.40696927 |
| 103 | vitamin D metabolic process (GO:0042359) | 3.37079226 |
| 104 | phenol-containing compound catabolic process (GO:0019336) | 3.35532918 |
| 105 | auditory receptor cell differentiation (GO:0042491) | 3.34583119 |
| 106 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.34334765 |
| 107 | response to nitric oxide (GO:0071731) | 3.32101690 |
| 108 | ceramide catabolic process (GO:0046514) | 3.31526090 |
| 109 | cGMP-mediated signaling (GO:0019934) | 3.30004699 |
| 110 | vitamin biosynthetic process (GO:0009110) | 3.29263068 |
| 111 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.28977819 |
| 112 | protein-lipid complex assembly (GO:0065005) | 3.28792954 |
| 113 | sulfur compound transport (GO:0072348) | 3.28284314 |
| 114 | regulation of protein glycosylation (GO:0060049) | 3.27429159 |
| 115 | renal filtration (GO:0097205) | 3.26710484 |
| 116 | drug transport (GO:0015893) | 3.25919367 |
| 117 | drug transmembrane transport (GO:0006855) | 3.24398110 |
| 118 | cobalamin metabolic process (GO:0009235) | 3.21912399 |
| 119 | primary alcohol metabolic process (GO:0034308) | 3.20742707 |
| 120 | auditory behavior (GO:0031223) | 3.18672500 |
| 121 | glycerol metabolic process (GO:0006071) | 3.17906881 |
| 122 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.17549677 |
| 123 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.12237694 |
| 124 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.10467115 |
| 125 | modified amino acid transport (GO:0072337) | 3.09979961 |
| 126 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.09709669 |
| 127 | proline transport (GO:0015824) | 3.09408063 |
| 128 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.07983849 |
| 129 | vitamin transport (GO:0051180) | 3.06234299 |
| 130 | negative regulation of steroid metabolic process (GO:0045939) | 3.05922052 |
| 131 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.04246038 |
| 132 | bicarbonate transport (GO:0015701) | 3.04126608 |
| 133 | regulation of pseudopodium assembly (GO:0031272) | 3.03716944 |
| 134 | cellular response to reactive nitrogen species (GO:1902170) | 3.02321065 |
| 135 | digestive system process (GO:0022600) | 3.01804169 |
| 136 | urate metabolic process (GO:0046415) | 3.01142061 |
| 137 | glucose 6-phosphate metabolic process (GO:0051156) | 2.99954567 |
| 138 | regulation of beta-amyloid formation (GO:1902003) | 2.99270727 |
| 139 | head development (GO:0060322) | 2.98939753 |
| 140 | phospholipid efflux (GO:0033700) | 2.98170517 |
| 141 | vitamin A metabolic process (GO:0006776) | 2.97812323 |
| 142 | regulation of pigment cell differentiation (GO:0050932) | 2.97305679 |
| 143 | cytidine deamination (GO:0009972) | 2.95715467 |
| 144 | cytidine catabolic process (GO:0006216) | 2.95715467 |
| 145 | otic vesicle formation (GO:0030916) | 2.94232663 |
| 146 | mammary gland alveolus development (GO:0060749) | 2.93758866 |
| 147 | cellular response to oxygen radical (GO:0071450) | 2.89838332 |
| 148 | removal of superoxide radicals (GO:0019430) | 2.89838332 |
| 149 | cellular response to superoxide (GO:0071451) | 2.89838332 |
| 150 | dentate gyrus development (GO:0021542) | 2.82373916 |
| 151 | copper ion homeostasis (GO:0055070) | 2.80797698 |
| 152 | regulation of potassium ion transport (GO:0043266) | 2.80212493 |
| 153 | macroautophagy (GO:0016236) | 2.75671261 |
| 154 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.74071735 |
| 155 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.74071735 |
| 156 | secondary metabolic process (GO:0019748) | 2.67446904 |
| 157 | response to auditory stimulus (GO:0010996) | 2.65990847 |
| 158 | positive regulation of respiratory burst (GO:0060267) | 2.61159490 |
| 159 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.60986394 |
| 160 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.59925904 |
| 161 | response to nitrosative stress (GO:0051409) | 2.59818772 |
| 162 | flavonoid metabolic process (GO:0009812) | 2.54975149 |
| 163 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.54794728 |
| 164 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.52949973 |
| 165 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.52949973 |
| 166 | innervation (GO:0060384) | 2.50240493 |
| 167 | cellular response to drug (GO:0035690) | 2.49133845 |
| 168 | lung vasculature development (GO:0060426) | 2.47246076 |
| 169 | S-adenosylmethionine metabolic process (GO:0046500) | 2.46586172 |
| 170 | hyperosmotic salinity response (GO:0042538) | 2.42055195 |
| 171 | regulation of cation channel activity (GO:2001257) | 2.42014219 |
| 172 | folic acid metabolic process (GO:0046655) | 2.38838902 |
| 173 | branched-chain amino acid catabolic process (GO:0009083) | 2.38662022 |
| 174 | glomerular filtration (GO:0003094) | 2.37394489 |
| 175 | lung epithelium development (GO:0060428) | 2.35019002 |
| 176 | chloride transmembrane transport (GO:1902476) | 2.34767027 |
| 177 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.34688018 |
| 178 | relaxation of cardiac muscle (GO:0055119) | 2.34178211 |
| 179 | glial cell proliferation (GO:0014009) | 2.33481760 |
| 180 | positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052) | 2.33358367 |
| 181 | positive regulation of proteasomal protein catabolic process (GO:1901800) | 2.33223257 |
| 182 | sodium-independent organic anion transport (GO:0043252) | 2.32859252 |
| 183 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.32036823 |
| 184 | positive regulation of bone mineralization (GO:0030501) | 2.31882521 |
| 185 | serotonin metabolic process (GO:0042428) | 2.29883657 |
| 186 | positive regulation of cellular protein catabolic process (GO:1903364) | 2.28325183 |
| 187 | chloride transport (GO:0006821) | 2.25530821 |
| 188 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.25243494 |
| 189 | response to superoxide (GO:0000303) | 2.24250336 |
| 190 | positive regulation of cholesterol efflux (GO:0010875) | 2.23867381 |
| 191 | membrane repolarization during action potential (GO:0086011) | 13.6248997 |
| 192 | tongue development (GO:0043586) | 13.2838682 |
| 193 | potassium ion export (GO:0071435) | 12.4460853 |
| 194 | angiotensin maturation (GO:0002003) | 12.0165098 |
| 195 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 10.8473196 |
| 196 | potassium ion import (GO:0010107) | 10.8060686 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 4.01187339 |
| 2 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.68542962 |
| 3 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 3.29367414 |
| 4 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.21468555 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.04499465 |
| 6 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 2.52032678 |
| 7 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.49603904 |
| 8 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.40662832 |
| 9 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.33368946 |
| 10 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.29652901 |
| 11 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.26905198 |
| 12 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 2.26168465 |
| 13 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.16879461 |
| 14 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.11275984 |
| 15 | TP53_18474530_ChIP-ChIP_U2OS_Human | 2.08910958 |
| 16 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.07416959 |
| 17 | CDX2_22108803_ChIP-Seq_LS180_Human | 2.01365474 |
| 18 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.99925376 |
| 19 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.96836900 |
| 20 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.93455497 |
| 21 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.92478178 |
| 22 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.92125394 |
| 23 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.92125394 |
| 24 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.92125394 |
| 25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.86563181 |
| 26 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.84882158 |
| 27 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.84858968 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 1.83183684 |
| 29 | VDR_22108803_ChIP-Seq_LS180_Human | 1.82716675 |
| 30 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.80120675 |
| 31 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.79619769 |
| 32 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.77451468 |
| 33 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.74458592 |
| 34 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.74016772 |
| 35 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.74016772 |
| 36 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.73361703 |
| 37 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.73154173 |
| 38 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.71662554 |
| 39 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.67688037 |
| 40 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.65685317 |
| 41 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.64599832 |
| 42 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.64432944 |
| 43 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.62770745 |
| 44 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.62414448 |
| 45 | TP53_16413492_ChIP-PET_HCT116_Human | 1.62389179 |
| 46 | FUS_26573619_Chip-Seq_HEK293_Human | 1.61048782 |
| 47 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.58723972 |
| 48 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.58085169 |
| 49 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.57313707 |
| 50 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.56645637 |
| 51 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.55767219 |
| 52 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.50231421 |
| 53 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.48338005 |
| 54 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.45868419 |
| 55 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.45806472 |
| 56 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.42881517 |
| 57 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.42201891 |
| 58 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.41925539 |
| 59 | * TCF4_22108803_ChIP-Seq_LS180_Human | 1.40594249 |
| 60 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.39708981 |
| 61 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.37323183 |
| 62 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.35696466 |
| 63 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.35359530 |
| 64 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.34708291 |
| 65 | P300_19829295_ChIP-Seq_ESCs_Human | 1.32505942 |
| 66 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.32095371 |
| 67 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.32066820 |
| 68 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.31342836 |
| 69 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.30948766 |
| 70 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.30594332 |
| 71 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.30451061 |
| 72 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.28481543 |
| 73 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.28257133 |
| 74 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.27580862 |
| 75 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.27093987 |
| 76 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.27048515 |
| 77 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.26379348 |
| 78 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.25250949 |
| 79 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.25213562 |
| 80 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.24791959 |
| 81 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.23837094 |
| 82 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.23754954 |
| 83 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.23495363 |
| 84 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.23304872 |
| 85 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.23161861 |
| 86 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.22880784 |
| 87 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.22767656 |
| 88 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.21268883 |
| 89 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.21156134 |
| 90 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.20962749 |
| 91 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.20934270 |
| 92 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.20027079 |
| 93 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.19690269 |
| 94 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.19634274 |
| 95 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.17332048 |
| 96 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.16714953 |
| 97 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16652178 |
| 98 | AR_25329375_ChIP-Seq_VCAP_Human | 1.16449266 |
| 99 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.16383037 |
| 100 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.15620452 |
| 101 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.15414864 |
| 102 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.14926328 |
| 103 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.14895317 |
| 104 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.14808016 |
| 105 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.14692352 |
| 106 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.14376443 |
| 107 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.13250542 |
| 108 | STAT3_23295773_ChIP-Seq_U87_Human | 1.13077705 |
| 109 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.12647034 |
| 110 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.12647034 |
| 111 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.11979584 |
| 112 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.11359923 |
| 113 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.10988263 |
| 114 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.10785044 |
| 115 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.10429968 |
| 116 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.10326724 |
| 117 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.10326724 |
| 118 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.09959827 |
| 119 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.09670842 |
| 120 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.09620580 |
| 121 | RXR_22108803_ChIP-Seq_LS180_Human | 1.08385113 |
| 122 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.08347338 |
| 123 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.08325120 |
| 124 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.08135736 |
| 125 | CJUN_26792858_Chip-Seq_BT549_Human | 1.07548177 |
| 126 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.06694893 |
| 127 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.06172880 |
| 128 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.05929988 |
| 129 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.05554783 |
| 130 | * GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.05346602 |
| 131 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.05327922 |
| 132 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.05238351 |
| 133 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.04700700 |
| 134 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.04470333 |
| 135 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.04132667 |
| 136 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 1.03506539 |
| 137 | NFYA_21822215_ChIP-Seq_K562_Human | 1.02873303 |
| 138 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.02246192 |
| 139 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.02175571 |
| 140 | ETV1_20927104_ChIP-Seq_GIST48_Human | 1.02159925 |
| 141 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.01951172 |
| 142 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.01838517 |
| 143 | NFYB_21822215_ChIP-Seq_K562_Human | 1.01358904 |
| 144 | TBL1_22424771_ChIP-Seq_293T_Human | 1.01280110 |
| 145 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.01272072 |
| 146 | NCOR_22424771_ChIP-Seq_293T_Human | 0.99500658 |
| 147 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.99402053 |
| 148 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.98720627 |
| 149 | TCF4_23295773_ChIP-Seq_U87_Human | 0.98585183 |
| 150 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.97810818 |
| 151 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.97716557 |
| 152 | AR_20517297_ChIP-Seq_VCAP_Human | 0.97617041 |
| 153 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.96541311 |
| 154 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.96512586 |
| 155 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.95776499 |
| 156 | KDM2B_26808549_Chip-Seq_REH_Human | 0.95502030 |
| 157 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.95432199 |
| 158 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.94718810 |
| 159 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.94094193 |
| 160 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.93858387 |
| 161 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.93566073 |
| 162 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.93044057 |
| 163 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.93044057 |
| 164 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.92968458 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 9.35289940 |
| 2 | MP0000372_irregular_coat_pigmentation | 5.64020038 |
| 3 | MP0001666_abnormal_nutrient_absorption | 5.00328167 |
| 4 | MP0003011_delayed_dark_adaptation | 4.82076436 |
| 5 | MP0003183_abnormal_peptide_metabolism | 4.53113467 |
| 6 | MP0004147_increased_porphyrin_level | 4.15781765 |
| 7 | MP0001346_abnormal_lacrimal_gland | 4.14164113 |
| 8 | MP0005365_abnormal_bile_salt | 3.76276189 |
| 9 | MP0004019_abnormal_vitamin_homeostasis | 3.63124950 |
| 10 | MP0004264_abnormal_extraembryonic_tissu | 3.51964950 |
| 11 | MP0009379_abnormal_foot_pigmentation | 3.40861326 |
| 12 | MP0005171_absent_coat_pigmentation | 3.17114615 |
| 13 | MP0000566_synostosis | 3.10623790 |
| 14 | MP0005248_abnormal_Harderian_gland | 2.97894907 |
| 15 | MP0001958_emphysema | 2.70379330 |
| 16 | MP0005408_hypopigmentation | 2.59297456 |
| 17 | MP0010155_abnormal_intestine_physiology | 2.32573464 |
| 18 | MP0010234_abnormal_vibrissa_follicle | 2.12267656 |
| 19 | MP0003868_abnormal_feces_composition | 2.09226589 |
| 20 | MP0008004_abnormal_stomach_pH | 13.4681082 |
| 21 | MP0001764_abnormal_homeostasis | 1.95867279 |
| 22 | MP0005409_darkened_coat_color | 1.88551653 |
| 23 | MP0003806_abnormal_nucleotide_metabolis | 1.86194655 |
| 24 | MP0000538_abnormal_urinary_bladder | 1.77472424 |
| 25 | MP0009643_abnormal_urine_homeostasis | 1.74718136 |
| 26 | MP0003252_abnormal_bile_duct | 1.70796178 |
| 27 | MP0005379_endocrine/exocrine_gland_phen | 1.64581763 |
| 28 | MP0004272_abnormal_basement_membrane | 1.63966971 |
| 29 | MP0002876_abnormal_thyroid_physiology | 1.61536477 |
| 30 | MP0008789_abnormal_olfactory_epithelium | 1.57961348 |
| 31 | MP0010030_abnormal_orbit_morphology | 1.57670163 |
| 32 | MP0005174_abnormal_tail_pigmentation | 1.57501398 |
| 33 | MP0005666_abnormal_adipose_tissue | 1.54921731 |
| 34 | MP0003866_abnormal_defecation | 1.51865853 |
| 35 | MP0001177_atelectasis | 1.50824185 |
| 36 | MP0002822_catalepsy | 1.49165056 |
| 37 | MP0003718_maternal_effect | 1.48442088 |
| 38 | MP0003186_abnormal_redox_activity | 1.46066861 |
| 39 | MP0002108_abnormal_muscle_morphology | 1.39024180 |
| 40 | MP0000490_abnormal_crypts_of | 1.38929149 |
| 41 | MP0005394_taste/olfaction_phenotype | 1.37707738 |
| 42 | MP0005499_abnormal_olfactory_system | 1.37707738 |
| 43 | MP0001188_hyperpigmentation | 1.36774224 |
| 44 | MP0001765_abnormal_ion_homeostasis | 1.36433689 |
| 45 | MP0004782_abnormal_surfactant_physiolog | 1.34678325 |
| 46 | MP0001501_abnormal_sleep_pattern | 1.33969298 |
| 47 | MP0005636_abnormal_mineral_homeostasis | 1.33170088 |
| 48 | MP0000462_abnormal_digestive_system | 1.30957660 |
| 49 | MP0001324_abnormal_eye_pigmentation | 1.27819174 |
| 50 | MP0004270_analgesia | 1.25676918 |
| 51 | MP0000477_abnormal_intestine_morphology | 1.23389818 |
| 52 | MP0002971_abnormal_brown_adipose | 1.22844999 |
| 53 | MP0009840_abnormal_foam_cell | 1.18271799 |
| 54 | MP0005448_abnormal_energy_balance | 1.17668329 |
| 55 | MP0002136_abnormal_kidney_physiology | 1.16541414 |
| 56 | MP0005075_abnormal_melanosome_morpholog | 1.14566395 |
| 57 | MP0005166_decreased_susceptibility_to | 1.14016636 |
| 58 | MP0002118_abnormal_lipid_homeostasis | 1.13725673 |
| 59 | MP0001664_abnormal_digestion | 1.12777028 |
| 60 | MP0000569_abnormal_digit_pigmentation | 1.12393639 |
| 61 | MP0000678_abnormal_parathyroid_gland | 1.12044033 |
| 62 | MP0001873_stomach_inflammation | 1.10911170 |
| 63 | MP0005670_abnormal_white_adipose | 1.10693954 |
| 64 | MP0010352_gastrointestinal_tract_polyps | 1.09748707 |
| 65 | MP0003632_abnormal_nervous_system | 1.09618408 |
| 66 | MP0003279_aneurysm | 1.08179182 |
| 67 | MP0000470_abnormal_stomach_morphology | 1.08143271 |
| 68 | MP0000516_abnormal_urinary_system | 1.07326769 |
| 69 | MP0005367_renal/urinary_system_phenotyp | 1.07326769 |
| 70 | MP0000015_abnormal_ear_pigmentation | 1.05305005 |
| 71 | MP0001756_abnormal_urination | 1.04065301 |
| 72 | MP0003786_premature_aging | 1.00966544 |
| 73 | MP0000371_diluted_coat_color | 0.99438877 |
| 74 | MP0003136_yellow_coat_color | 0.96718820 |
| 75 | MP0000537_abnormal_urethra_morphology | 0.94621660 |
| 76 | MP0004043_abnormal_pH_regulation | 0.94444282 |
| 77 | MP0001663_abnormal_digestive_system | 0.93043832 |
| 78 | MP0002877_abnormal_melanocyte_morpholog | 0.92943428 |
| 79 | MP0000631_abnormal_neuroendocrine_gland | 0.92737385 |
| 80 | MP0003191_abnormal_cellular_cholesterol | 0.92273627 |
| 81 | MP0000230_abnormal_systemic_arterial | 0.90849551 |
| 82 | MP0010678_abnormal_skin_adnexa | 0.88597922 |
| 83 | MP0005646_abnormal_pituitary_gland | 0.88108854 |
| 84 | MP0002928_abnormal_bile_duct | 0.87558343 |
| 85 | MP0003941_abnormal_skin_development | 0.87548950 |
| 86 | MP0003879_abnormal_hair_cell | 0.86076512 |
| 87 | MP0009697_abnormal_copulation | 0.85502727 |
| 88 | MP0003690_abnormal_glial_cell | 0.85490473 |
| 89 | MP0001919_abnormal_reproductive_system | 0.84295819 |
| 90 | MP0005375_adipose_tissue_phenotype | 0.82926547 |
| 91 | MP0009780_abnormal_chondrocyte_physiolo | 0.82341380 |
| 92 | MP0002168_other_aberrant_phenotype | 0.81491871 |
| 93 | MP0005381_digestive/alimentary_phenotyp | 0.81379466 |
| 94 | MP0002295_abnormal_pulmonary_circulatio | 0.79028295 |
| 95 | MP0002133_abnormal_respiratory_system | 0.78803964 |
| 96 | MP0005388_respiratory_system_phenotype | 0.78803964 |
| 97 | MP0002254_reproductive_system_inflammat | 0.77994088 |
| 98 | MP0000609_abnormal_liver_physiology | 0.77385770 |
| 99 | MP0009115_abnormal_fat_cell | 0.76860417 |
| 100 | MP0004381_abnormal_hair_follicle | 0.74303113 |
| 101 | MP0002090_abnormal_vision | 0.73415610 |
| 102 | MP0004859_abnormal_synaptic_plasticity | 0.72490174 |
| 103 | MP0009384_cardiac_valve_regurgitation | 0.71634079 |
| 104 | MP0005197_abnormal_uvea_morphology | 0.71144462 |
| 105 | MP0003631_nervous_system_phenotype | 0.70722384 |
| 106 | MP0000383_abnormal_hair_follicle | 0.70606071 |
| 107 | MP0005319_abnormal_enzyme/_coenzyme | 0.70353061 |
| 108 | MP0005535_abnormal_body_temperature | 0.69615327 |
| 109 | MP0003938_abnormal_ear_development | 0.69538788 |
| 110 | MP0008875_abnormal_xenobiotic_pharmacok | 0.69523301 |
| 111 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.69262531 |
| 112 | MP0005085_abnormal_gallbladder_physiolo | 0.68957271 |
| 113 | MP0008961_abnormal_basal_metabolism | 0.66919880 |
| 114 | MP0005551_abnormal_eye_electrophysiolog | 0.65798696 |
| 115 | MP0008438_abnormal_cutaneous_collagen | 0.64696756 |
| 116 | MP0001186_pigmentation_phenotype | 0.64421364 |
| 117 | MP0005253_abnormal_eye_physiology | 0.63976720 |
| 118 | MP0002098_abnormal_vibrissa_morphology | 0.63450288 |
| 119 | MP0008775_abnormal_heart_ventricle | 0.63405685 |
| 120 | MP0001440_abnormal_grooming_behavior | 0.60750363 |
| 121 | MP0008872_abnormal_physiological_respon | 0.58607135 |
| 122 | MP0005332_abnormal_amino_acid | 0.58449048 |
| 123 | MP0000778_abnormal_nervous_system | 0.57697215 |
| 124 | MP0002938_white_spotting | 0.57520712 |
| 125 | MP0002095_abnormal_skin_pigmentation | 0.56506549 |
| 126 | MP0004142_abnormal_muscle_tone | 0.56431025 |
| 127 | MP0009642_abnormal_blood_homeostasis | 0.56135295 |
| 128 | MP0005376_homeostasis/metabolism_phenot | 0.55058761 |
| 129 | MP0003300_gastrointestinal_ulcer | 0.50293405 |
| 130 | MP0003638_abnormal_response/metabolism_ | 0.50070129 |
| 131 | MP0001845_abnormal_inflammatory_respons | 0.50029744 |
| 132 | MP0003137_abnormal_impulse_conducting | 0.49845309 |
| 133 | MP0002078_abnormal_glucose_homeostasis | 0.49722013 |
| 134 | MP0001485_abnormal_pinna_reflex | 0.49433713 |
| 135 | MP0005257_abnormal_intraocular_pressure | 0.48948100 |
| 136 | MP0004883_abnormal_blood_vessel | 0.48888990 |
| 137 | MP0000427_abnormal_hair_cycle | 0.48769376 |
| 138 | MP0004484_altered_response_of | 0.48733425 |
| 139 | MP0009764_decreased_sensitivity_to | 0.48012187 |
| 140 | MP0005503_abnormal_tendon_morphology | 0.47869661 |
| 141 | MP0002075_abnormal_coat/hair_pigmentati | 0.46648963 |
| 142 | MP0005410_abnormal_fertilization | 0.46319035 |
| 143 | MP0003315_abnormal_perineum_morphology | 0.46210166 |
| 144 | MP0000613_abnormal_salivary_gland | 0.45044964 |
| 145 | MP0002557_abnormal_social/conspecific_i | 0.45021452 |
| 146 | MP0000534_abnormal_ureter_morphology | 0.44488595 |
| 147 | MP0002396_abnormal_hematopoietic_system | 0.44396161 |
| 148 | MP0002751_abnormal_autonomic_nervous | 0.44179980 |
| 149 | MP0000762_abnormal_tongue_morphology | 0.44073815 |
| 150 | MP0010329_abnormal_lipoprotein_level | 0.43995279 |
| 151 | MP0004215_abnormal_myocardial_fiber | 0.43706322 |
| 152 | MP0002166_altered_tumor_susceptibility | 0.43479788 |
| 153 | MP0006138_congestive_heart_failure | 0.43018864 |
| 154 | MP0008469_abnormal_protein_level | 0.42988863 |
| 155 | MP0002896_abnormal_bone_mineralization | 0.42501460 |
| 156 | MP0002139_abnormal_hepatobiliary_system | 0.41792654 |
| 157 | MP0000647_abnormal_sebaceous_gland | 0.41786465 |
| 158 | MP0003633_abnormal_nervous_system | 0.41526313 |
| 159 | MP0000465_gastrointestinal_hemorrhage | 0.40875136 |
| 160 | MP0001944_abnormal_pancreas_morphology | 0.40469609 |
| 161 | MP0004233_abnormal_muscle_weight | 0.40227079 |
| 162 | MP0003953_abnormal_hormone_level | 0.39870929 |
| 163 | MP0005083_abnormal_biliary_tract | 0.37354866 |
| 164 | MP0002233_abnormal_nose_morphology | 0.35527416 |
| 165 | MP0000367_abnormal_coat/_hair | 0.34398606 |
| 166 | MP0008995_early_reproductive_senescence | 0.33604668 |
| 167 | MP0000681_abnormal_thyroid_gland | 0.32970029 |
| 168 | MP0001502_abnormal_circadian_rhythm | 0.32420881 |
| 169 | MP0003329_amyloid_beta_deposits | 0.31911763 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged QT interval (HP:0001657) | 7.14313650 |
| 2 | Abnormality of proline metabolism (HP:0010907) | 6.91953289 |
| 3 | Hydroxyprolinuria (HP:0003080) | 6.91953289 |
| 4 | Malnutrition (HP:0004395) | 6.86245662 |
| 5 | Abnormality of the fovea (HP:0000493) | 6.19717775 |
| 6 | Vascular calcification (HP:0004934) | 6.16592577 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.97830609 |
| 8 | Syncope (HP:0001279) | 5.64612733 |
| 9 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 5.62151080 |
| 10 | Chronic diarrhea (HP:0002028) | 5.58720333 |
| 11 | Cardiovascular calcification (HP:0011915) | 5.57235494 |
| 12 | Increased CSF protein (HP:0002922) | 5.40936802 |
| 13 | Acanthocytosis (HP:0001927) | 5.01638160 |
| 14 | Fat malabsorption (HP:0002630) | 4.84422789 |
| 15 | Confusion (HP:0001289) | 4.82512136 |
| 16 | Widely patent fontanelles and sutures (HP:0004492) | 4.75434994 |
| 17 | Orthostatic hypotension (HP:0001278) | 4.63050667 |
| 18 | Pigmentary retinal degeneration (HP:0001146) | 4.38545368 |
| 19 | Ileus (HP:0002595) | 4.37921276 |
| 20 | Hyperglycinuria (HP:0003108) | 4.23222581 |
| 21 | Abnormality of urine glucose concentration (HP:0011016) | 4.19885260 |
| 22 | Glycosuria (HP:0003076) | 4.19885260 |
| 23 | Abnormality of renal resorption (HP:0011038) | 3.99274722 |
| 24 | Hyperphosphatemia (HP:0002905) | 3.87867348 |
| 25 | Atrial fibrillation (HP:0005110) | 3.86364602 |
| 26 | Proximal tubulopathy (HP:0000114) | 3.86128101 |
| 27 | Choroideremia (HP:0001139) | 3.80744694 |
| 28 | Congenital sensorineural hearing impairment (HP:0008527) | 3.70484142 |
| 29 | Abnormal EKG (HP:0003115) | 3.66862274 |
| 30 | Metabolic alkalosis (HP:0200114) | 3.59691396 |
| 31 | Primary atrial arrhythmia (HP:0001692) | 3.59551640 |
| 32 | Abnormality of glycine metabolism (HP:0010895) | 3.55401143 |
| 33 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.55401143 |
| 34 | Hypoplasia of the fovea (HP:0007750) | 3.47400374 |
| 35 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.47400374 |
| 36 | Ventricular arrhythmia (HP:0004308) | 3.43217001 |
| 37 | Supraventricular tachycardia (HP:0004755) | 3.41458288 |
| 38 | Potter facies (HP:0002009) | 3.40956634 |
| 39 | Facial shape deformation (HP:0011334) | 3.40956634 |
| 40 | Posterior subcapsular cataract (HP:0007787) | 3.38291331 |
| 41 | Supraventricular arrhythmia (HP:0005115) | 3.29549952 |
| 42 | Abnormality of the dental root (HP:0006486) | 3.27256120 |
| 43 | Taurodontia (HP:0000679) | 3.27256120 |
| 44 | Abnormality of permanent molar morphology (HP:0011071) | 3.27256120 |
| 45 | Nausea (HP:0002018) | 3.25096850 |
| 46 | Decreased circulating renin level (HP:0003351) | 3.23353185 |
| 47 | Hemiparesis (HP:0001269) | 3.21281367 |
| 48 | Abnormality of vitamin B metabolism (HP:0004340) | 3.21203963 |
| 49 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.18006242 |
| 50 | Hyperactive renin-angiotensin system (HP:0000841) | 3.17646297 |
| 51 | Wide cranial sutures (HP:0010537) | 3.15338087 |
| 52 | Steatorrhea (HP:0002570) | 3.11987581 |
| 53 | Abdominal distention (HP:0003270) | 3.07088830 |
| 54 | Systemic lupus erythematosus (HP:0002725) | 3.06451926 |
| 55 | Nephrolithiasis (HP:0000787) | 3.06131351 |
| 56 | Abnormality of molar morphology (HP:0011070) | 3.05819023 |
| 57 | Abnormality of molar (HP:0011077) | 3.05819023 |
| 58 | Aplasia involving bones of the extremities (HP:0009825) | 3.04271580 |
| 59 | Aplasia involving bones of the upper limbs (HP:0009823) | 3.04271580 |
| 60 | Aplasia of the phalanges of the hand (HP:0009802) | 3.04271580 |
| 61 | Enlarged epiphyses (HP:0010580) | 3.00581861 |
| 62 | Nonprogressive disorder (HP:0003680) | 2.97818800 |
| 63 | Arterial tortuosity (HP:0005116) | 2.95446808 |
| 64 | Oligomenorrhea (HP:0000876) | 2.94603020 |
| 65 | Alkalosis (HP:0001948) | 2.88346849 |
| 66 | Abnormality of the dental pulp (HP:0006479) | 2.83900176 |
| 67 | Thin bony cortex (HP:0002753) | 2.83113317 |
| 68 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.82977679 |
| 69 | Hypolipoproteinemia (HP:0010981) | 2.82393718 |
| 70 | Spinal muscular atrophy (HP:0007269) | 2.77423547 |
| 71 | Dysautonomia (HP:0002459) | 2.77028935 |
| 72 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.75159668 |
| 73 | Protuberant abdomen (HP:0001538) | 2.72142463 |
| 74 | Vascular tortuosity (HP:0004948) | 2.71878851 |
| 75 | Abnormality of renin-angiotensin system (HP:0000847) | 2.70733733 |
| 76 | Abnormality of vitamin metabolism (HP:0100508) | 2.69202285 |
| 77 | Megaloblastic anemia (HP:0001889) | 2.68877040 |
| 78 | White forelock (HP:0002211) | 2.68513790 |
| 79 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.64594604 |
| 80 | Urethral obstruction (HP:0000796) | 2.64491857 |
| 81 | Hyperphosphaturia (HP:0003109) | 2.62481228 |
| 82 | Hyperuricemia (HP:0002149) | 2.61891638 |
| 83 | Increased purine levels (HP:0004368) | 2.61891638 |
| 84 | Patchy hypopigmentation of hair (HP:0011365) | 2.61131205 |
| 85 | Abnormality of incisor morphology (HP:0011063) | 2.58620735 |
| 86 | Abnormal urine phosphate concentration (HP:0012599) | 2.57243375 |
| 87 | Hypopigmentation of the fundus (HP:0007894) | 2.57205828 |
| 88 | Hand muscle atrophy (HP:0009130) | 2.55094317 |
| 89 | Hypoplasia of the uterus (HP:0000013) | 2.52073859 |
| 90 | Xanthomatosis (HP:0000991) | 2.52003123 |
| 91 | Bilateral microphthalmos (HP:0007633) | 2.47639512 |
| 92 | Paraplegia (HP:0010550) | 2.46934869 |
| 93 | Delayed epiphyseal ossification (HP:0002663) | 2.45651301 |
| 94 | Neonatal short-limb short stature (HP:0008921) | 2.45214228 |
| 95 | Hypophosphatemia (HP:0002148) | 2.43724252 |
| 96 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.42003301 |
| 97 | Villous atrophy (HP:0011473) | 2.42003301 |
| 98 | Hypothermia (HP:0002045) | 2.40415654 |
| 99 | Distal lower limb muscle weakness (HP:0009053) | 2.39188789 |
| 100 | Epidermoid cyst (HP:0200040) | 2.38922887 |
| 101 | Obstructive sleep apnea (HP:0002870) | 2.38158107 |
| 102 | Tarsal synostosis (HP:0008368) | 2.37871415 |
| 103 | Abnormal glucose tolerance (HP:0001952) | 2.34643379 |
| 104 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 2.33413542 |
| 105 | Neurodegeneration (HP:0002180) | 2.31127317 |
| 106 | True hermaphroditism (HP:0010459) | 2.30897360 |
| 107 | Abnormality of purine metabolism (HP:0004352) | 2.29526687 |
| 108 | Hyperammonemia (HP:0001987) | 2.28577576 |
| 109 | Synostosis involving bones of the lower limbs (HP:0009138) | 2.27110756 |
| 110 | Synostosis involving bones of the feet (HP:0009140) | 2.27110756 |
| 111 | Abnormality of magnesium homeostasis (HP:0004921) | 2.26503958 |
| 112 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.26284719 |
| 113 | Abnormal biliary tract morphology (HP:0012440) | 2.26003057 |
| 114 | Blue irides (HP:0000635) | 2.25704214 |
| 115 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.23406809 |
| 116 | Carpal synostosis (HP:0009702) | 2.22239248 |
| 117 | Sleep apnea (HP:0010535) | 2.19747732 |
| 118 | Menorrhagia (HP:0000132) | 2.19552610 |
| 119 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.19279123 |
| 120 | Poikilocytosis (HP:0004447) | 2.18850711 |
| 121 | Epiphyseal dysplasia (HP:0002656) | 2.17211684 |
| 122 | Abnormality of the costochondral junction (HP:0000919) | 2.17027122 |
| 123 | Subcapsular cataract (HP:0000523) | 2.16196965 |
| 124 | Chorioretinal atrophy (HP:0000533) | 2.14198424 |
| 125 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.13771094 |
| 126 | Tubulointerstitial nephritis (HP:0001970) | 2.13589934 |
| 127 | Synostosis of carpal bones (HP:0005048) | 2.13563048 |
| 128 | Flat acetabular roof (HP:0003180) | 2.13500543 |
| 129 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.13054206 |
| 130 | Increased circulating renin level (HP:0000848) | 2.12184466 |
| 131 | Abnormality of the aortic arch (HP:0012303) | 2.11847319 |
| 132 | Stomach cancer (HP:0012126) | 2.10510304 |
| 133 | Interstitial pulmonary disease (HP:0006530) | 2.08075914 |
| 134 | Enlarged kidneys (HP:0000105) | 2.04929030 |
| 135 | Abnormality of nucleobase metabolism (HP:0010932) | 2.04500860 |
| 136 | Metabolic acidosis (HP:0001942) | 2.03869219 |
| 137 | Abnormal autonomic nervous system physiology (HP:0012332) | 2.02676532 |
| 138 | Right ventricular cardiomyopathy (HP:0011663) | 2.02388234 |
| 139 | Scotoma (HP:0000575) | 2.01129642 |
| 140 | Distal upper limb amyotrophy (HP:0007149) | 2.00147959 |
| 141 | Upper limb amyotrophy (HP:0009129) | 2.00147959 |
| 142 | Ventricular fibrillation (HP:0001663) | 12.2453786 |
| 143 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 10.1951483 |
| 144 | Biliary tract neoplasm (HP:0100574) | 1.99550838 |
| 145 | Abnormality of renal excretion (HP:0011036) | 1.99349459 |
| 146 | Abnormality of the vitreous humor (HP:0004327) | 1.97463500 |
| 147 | Sudden cardiac death (HP:0001645) | 1.95748625 |
| 148 | Hyperventilation (HP:0002883) | 1.95384766 |
| 149 | Hypoplasia of dental enamel (HP:0006297) | 1.93408155 |
| 150 | Fetal akinesia sequence (HP:0001989) | 1.92489791 |
| 151 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.91383841 |
| 152 | Focal segmental glomerulosclerosis (HP:0000097) | 1.90850542 |
| 153 | Hypoalphalipoproteinemia (HP:0003233) | 1.86354832 |
| 154 | Renal tubular acidosis (HP:0001947) | 1.86281090 |
| 155 | Abnormality of the nasal septum (HP:0000419) | 1.84982198 |
| 156 | Hypokalemia (HP:0002900) | 1.83709811 |
| 157 | Abnormal albumin level (HP:0012116) | 1.83524205 |
| 158 | Hypoalbuminemia (HP:0003073) | 1.83524205 |
| 159 | Abnormal pancreas size (HP:0012094) | 1.82945869 |
| 160 | Rhinitis (HP:0012384) | 1.82584538 |
| 161 | Annular pancreas (HP:0001734) | 1.78542015 |
| 162 | Pancreatitis (HP:0001733) | 1.78525903 |
| 163 | Hypocalcemia (HP:0002901) | 1.78153355 |
| 164 | Symptomatic seizures (HP:0011145) | 1.77834020 |
| 165 | Synostosis involving bones of the hand (HP:0004278) | 1.77010358 |
| 166 | Hypotension (HP:0002615) | 1.76341725 |
| 167 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.76246707 |
| 168 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.74439899 |
| 169 | Action tremor (HP:0002345) | 1.72844843 |
| 170 | Carpal bone hypoplasia (HP:0001498) | 1.71620010 |
| 171 | Long clavicles (HP:0000890) | 1.68648997 |
| 172 | Pancreatic fibrosis (HP:0100732) | 1.67541723 |
| 173 | Metaphyseal irregularity (HP:0003025) | 1.67080975 |
| 174 | Cerebral palsy (HP:0100021) | 1.66844864 |
| 175 | Petechiae (HP:0000967) | 1.65749603 |
| 176 | Lethargy (HP:0001254) | 1.64654851 |
| 177 | Hyperaldosteronism (HP:0000859) | 1.64301323 |
| 178 | Abnormality of the humerus (HP:0003063) | 1.64026390 |
| 179 | Renal tubular dysfunction (HP:0000124) | 1.63380891 |
| 180 | Abnormality of the lacrimal duct (HP:0011481) | 1.62744364 |
| 181 | Bifid scrotum (HP:0000048) | 1.62432651 |
| 182 | Intrahepatic cholestasis (HP:0001406) | 1.60116949 |
| 183 | Hyperparathyroidism (HP:0000843) | 1.59560154 |
| 184 | Irritability (HP:0000737) | 1.57624373 |
| 185 | Occipital encephalocele (HP:0002085) | 1.57292749 |
| 186 | Tetany (HP:0001281) | 1.57162167 |
| 187 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.56568337 |
| 188 | Hypophosphatemic rickets (HP:0004912) | 1.56539465 |
| 189 | Scanning speech (HP:0002168) | 1.56311556 |
| 190 | Abnormality of the upper arm (HP:0001454) | 1.55319560 |
| 191 | Abnormal urine output (HP:0012590) | 1.53908519 |
| 192 | Dicarboxylic aciduria (HP:0003215) | 1.53827041 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 9.45925156 |
| 2 | STK39 | 6.58058633 |
| 3 | WNK4 | 5.07753809 |
| 4 | MST4 | 4.38161092 |
| 5 | GRK1 | 4.17394069 |
| 6 | FRK | 3.86080376 |
| 7 | RIPK1 | 2.77787017 |
| 8 | CAMKK1 | 2.46291443 |
| 9 | MAP3K10 | 2.26096822 |
| 10 | CAMKK2 | 2.17950773 |
| 11 | WNK1 | 2.10445510 |
| 12 | AKT3 | 2.01758849 |
| 13 | MAP3K2 | 1.97357648 |
| 14 | LMTK2 | 1.93474715 |
| 15 | TESK2 | 1.91757965 |
| 16 | STK10 | 1.86102751 |
| 17 | FGFR2 | 1.85842900 |
| 18 | TRPM7 | 1.71104672 |
| 19 | BMPR1B | 1.67631196 |
| 20 | EPHB2 | 1.67276202 |
| 21 | MST1R | 1.64348827 |
| 22 | MAP3K3 | 1.51606244 |
| 23 | WNK3 | 1.47375608 |
| 24 | NEK6 | 1.46260410 |
| 25 | ERN1 | 1.45929843 |
| 26 | SGK2 | 1.41414972 |
| 27 | MAP3K12 | 1.41101557 |
| 28 | PDK2 | 1.38366145 |
| 29 | TESK1 | 1.36846537 |
| 30 | PINK1 | 1.34706619 |
| 31 | EPHA3 | 1.31082069 |
| 32 | ERBB2 | 1.30573671 |
| 33 | GRK6 | 1.28869013 |
| 34 | PRPF4B | 1.21616510 |
| 35 | PRKCQ | 1.20793764 |
| 36 | PHKG1 | 1.18146581 |
| 37 | PHKG2 | 1.18146581 |
| 38 | JAK2 | 1.18115642 |
| 39 | SIK1 | 1.17831982 |
| 40 | EPHA4 | 1.17561030 |
| 41 | ERBB3 | 1.17540949 |
| 42 | DDR2 | 1.17344975 |
| 43 | MYLK | 1.17207445 |
| 44 | MAP3K14 | 1.13930283 |
| 45 | LRRK2 | 1.13593638 |
| 46 | BMPR2 | 1.11795034 |
| 47 | EPHA2 | 1.11762594 |
| 48 | PTK6 | 1.05724789 |
| 49 | SGK223 | 1.04218724 |
| 50 | SGK494 | 1.04218724 |
| 51 | TNIK | 1.01216612 |
| 52 | OXSR1 | 0.98577895 |
| 53 | FGFR3 | 0.96798591 |
| 54 | CDK8 | 0.96141632 |
| 55 | INSRR | 0.95147487 |
| 56 | EPHB1 | 0.92418689 |
| 57 | IRAK1 | 0.92100209 |
| 58 | SGK3 | 0.88923693 |
| 59 | MAP4K2 | 0.88012669 |
| 60 | PRKCE | 0.86854126 |
| 61 | BRSK2 | 0.85245819 |
| 62 | LIMK1 | 0.83560017 |
| 63 | MET | 0.82701323 |
| 64 | CSNK1A1L | 0.78985235 |
| 65 | CAMK4 | 0.77825660 |
| 66 | JAK1 | 0.75493721 |
| 67 | ZAK | 0.75164702 |
| 68 | GRK7 | 0.74802993 |
| 69 | TYK2 | 0.74766515 |
| 70 | PRKAA2 | 0.73390860 |
| 71 | TGFBR2 | 0.70717570 |
| 72 | CASK | 0.69146658 |
| 73 | MAP2K6 | 0.68758421 |
| 74 | STK38L | 0.66266359 |
| 75 | NLK | 0.65948906 |
| 76 | ADRBK2 | 0.65802858 |
| 77 | STK24 | 0.65580386 |
| 78 | MELK | 0.64647501 |
| 79 | PRKCZ | 0.64617657 |
| 80 | ITK | 0.64588358 |
| 81 | NUAK1 | 0.64554432 |
| 82 | CHUK | 0.63966787 |
| 83 | FER | 0.63652159 |
| 84 | PIM1 | 0.63203588 |
| 85 | MAPK15 | 0.61978298 |
| 86 | PRKACG | 0.61631484 |
| 87 | ROCK1 | 0.59971631 |
| 88 | CDK5 | 0.59568591 |
| 89 | CSNK1G1 | 0.59300310 |
| 90 | MAP3K1 | 0.59024163 |
| 91 | PRKCG | 0.58544088 |
| 92 | FGFR4 | 0.57785236 |
| 93 | SGK1 | 0.57287501 |
| 94 | TGFBR1 | 0.56715050 |
| 95 | PLK2 | 0.55986807 |
| 96 | RPS6KB1 | 0.55501536 |
| 97 | MATK | 0.55345532 |
| 98 | ROCK2 | 0.54379318 |
| 99 | PDGFRB | 0.53826222 |
| 100 | LATS1 | 0.52729315 |
| 101 | PKN2 | 0.52531835 |
| 102 | * PRKCA | 0.52503076 |
| 103 | AKT2 | 0.52321200 |
| 104 | CDK6 | 0.48744052 |
| 105 | MARK3 | 0.48305563 |
| 106 | PRKG2 | 0.47069630 |
| 107 | RET | 0.46656424 |
| 108 | PAK4 | 0.46562494 |
| 109 | MAPK4 | 0.45609425 |
| 110 | BMX | 0.45327471 |
| 111 | HIPK2 | 0.44748438 |
| 112 | MAP2K7 | 0.43671357 |
| 113 | RPS6KB2 | 0.43603120 |
| 114 | MAPK13 | 0.43492106 |
| 115 | PIK3CA | 0.43197325 |
| 116 | CAMK1D | 0.42024070 |
| 117 | PTK2B | 0.41659990 |
| 118 | DYRK1A | 0.41586718 |
| 119 | PDK1 | 0.41182180 |
| 120 | DYRK1B | 0.39949400 |
| 121 | TEC | 0.39485391 |
| 122 | OBSCN | 0.39456763 |
| 123 | GSK3A | 0.38358204 |
| 124 | CSNK1A1 | 0.38233205 |
| 125 | MAP3K7 | 0.37030573 |
| 126 | ALK | 0.36702393 |
| 127 | RIPK4 | 0.36533595 |
| 128 | FGFR1 | 0.36084383 |
| 129 | PRKG1 | 0.35824942 |
| 130 | MAP4K1 | 0.35641553 |
| 131 | NTRK3 | 0.34986102 |
| 132 | STK3 | 0.33914876 |
| 133 | PIK3CG | 0.33793278 |
| 134 | PKN1 | 0.32977440 |
| 135 | CAMK1G | 0.32582615 |
| 136 | * PRKACA | 0.32541209 |
| 137 | BTK | 0.32399509 |
| 138 | CSNK1G3 | 0.32322597 |
| 139 | CSF1R | 0.31439609 |
| 140 | MAP2K2 | 0.31119864 |
| 141 | CAMK2A | 0.31080764 |
| 142 | CDC42BPA | 0.29702632 |
| 143 | PDPK1 | 0.28979466 |
| 144 | SRC | 0.28628736 |
| 145 | ERBB4 | 0.28583700 |
| 146 | CAMK2D | 0.28258496 |
| 147 | NEK9 | 0.28181580 |
| 148 | PTK2 | 0.27982738 |
| 149 | STK11 | 0.27631033 |
| 150 | STK38 | 0.27378935 |
| 151 | PRKCH | 0.27329964 |
| 152 | PRKCB | 0.26581829 |
| 153 | ADRBK1 | 0.25746517 |
| 154 | IGF1R | 0.23816942 |
| 155 | PRKCD | 0.23309969 |
| 156 | TAOK3 | 0.21305377 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 5.02962798 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 4.67832556 |
| 3 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 4.40446104 |
| 4 | Fat digestion and absorption_Homo sapiens_hsa04975 | 4.35433528 |
| 5 | Renin-angiotensin system_Homo sapiens_hsa04614 | 4.33834048 |
| 6 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 3.23201108 |
| 7 | Gastric acid secretion_Homo sapiens_hsa04971 | 3.03410751 |
| 8 | * Protein digestion and absorption_Homo sapiens_hsa04974 | 2.69658019 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.55814168 |
| 10 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.55037496 |
| 11 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.48783667 |
| 12 | Mineral absorption_Homo sapiens_hsa04978 | 2.36536479 |
| 13 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.36005460 |
| 14 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.32332804 |
| 15 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.26331936 |
| 16 | Retinol metabolism_Homo sapiens_hsa00830 | 2.22609620 |
| 17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.20190915 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 2.13267461 |
| 19 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.08977628 |
| 20 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.06332471 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.95158956 |
| 22 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.92567834 |
| 23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.92345447 |
| 24 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.87424737 |
| 25 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.73285666 |
| 26 | Bile secretion_Homo sapiens_hsa04976 | 1.64241376 |
| 27 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.54719614 |
| 28 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.51012102 |
| 29 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.47368476 |
| 30 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.46825097 |
| 31 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.42633158 |
| 32 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.41338290 |
| 33 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.31582043 |
| 34 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.27908426 |
| 35 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.27321347 |
| 36 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.25764756 |
| 37 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.21747955 |
| 38 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.20745687 |
| 39 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.18330006 |
| 40 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.17771200 |
| 41 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.14814614 |
| 42 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.14782356 |
| 43 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.13765967 |
| 44 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.13075095 |
| 45 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.04960648 |
| 46 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.00159297 |
| 47 | Galactose metabolism_Homo sapiens_hsa00052 | 0.97272863 |
| 48 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.96307028 |
| 49 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.96034427 |
| 50 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.93589145 |
| 51 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.89721614 |
| 52 | Asthma_Homo sapiens_hsa05310 | 0.89625286 |
| 53 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.88532033 |
| 54 | Salivary secretion_Homo sapiens_hsa04970 | 0.88128895 |
| 55 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.87852821 |
| 56 | Lysosome_Homo sapiens_hsa04142 | 0.85672106 |
| 57 | Peroxisome_Homo sapiens_hsa04146 | 0.81835501 |
| 58 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.80504373 |
| 59 | Phagosome_Homo sapiens_hsa04145 | 0.77839937 |
| 60 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.77446002 |
| 61 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.75958011 |
| 62 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.75011162 |
| 63 | Prostate cancer_Homo sapiens_hsa05215 | 0.74386804 |
| 64 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.72891177 |
| 65 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.72637769 |
| 66 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.72005390 |
| 67 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.71335341 |
| 68 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.70281950 |
| 69 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.69286544 |
| 70 | Alzheimers disease_Homo sapiens_hsa05010 | 0.68541008 |
| 71 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.66745845 |
| 72 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.66340528 |
| 73 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.65759547 |
| 74 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.64289217 |
| 75 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.62263536 |
| 76 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.62179053 |
| 77 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.61413799 |
| 78 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.60993365 |
| 79 | ABC transporters_Homo sapiens_hsa02010 | 0.59416264 |
| 80 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.58511167 |
| 81 | Huntingtons disease_Homo sapiens_hsa05016 | 0.57856948 |
| 82 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.57221317 |
| 83 | Parkinsons disease_Homo sapiens_hsa05012 | 0.56632691 |
| 84 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.56079876 |
| 85 | Olfactory transduction_Homo sapiens_hsa04740 | 0.55370339 |
| 86 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.54723205 |
| 87 | Allograft rejection_Homo sapiens_hsa05330 | 0.54233071 |
| 88 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.53254750 |
| 89 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.51570424 |
| 90 | Melanogenesis_Homo sapiens_hsa04916 | 0.51332508 |
| 91 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.51000209 |
| 92 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.50749771 |
| 93 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.48842985 |
| 94 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.48574592 |
| 95 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.48137220 |
| 96 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.48008520 |
| 97 | Circadian entrainment_Homo sapiens_hsa04713 | 0.47706060 |
| 98 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.46244370 |
| 99 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.45123967 |
| 100 | Carbon metabolism_Homo sapiens_hsa01200 | 0.44427526 |
| 101 | Gap junction_Homo sapiens_hsa04540 | 0.43239108 |
| 102 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.43030789 |
| 103 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.41570316 |
| 104 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.40154026 |
| 105 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.40036126 |
| 106 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.39323174 |
| 107 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.37812426 |
| 108 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.37782443 |
| 109 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.37666817 |
| 110 | Cocaine addiction_Homo sapiens_hsa05030 | 0.37642138 |
| 111 | Insulin secretion_Homo sapiens_hsa04911 | 0.37279695 |
| 112 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.36734940 |
| 113 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.36356271 |
| 114 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.36176084 |
| 115 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.35918602 |
| 116 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.35586488 |
| 117 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.33880348 |
| 118 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.28867752 |
| 119 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.28498276 |
| 120 | Renin secretion_Homo sapiens_hsa04924 | 0.27926908 |
| 121 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.26756042 |
| 122 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.26574606 |
| 123 | Metabolic pathways_Homo sapiens_hsa01100 | 0.26390911 |
| 124 | Prion diseases_Homo sapiens_hsa05020 | 0.25754897 |
| 125 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.25401572 |
| 126 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.24429422 |
| 127 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.22114073 |
| 128 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21714195 |
| 129 | Insulin resistance_Homo sapiens_hsa04931 | 0.19054394 |
| 130 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.18646614 |
| 131 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.14020477 |
| 132 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.13123550 |
| 133 | Tight junction_Homo sapiens_hsa04530 | 0.12979785 |
| 134 | Other glycan degradation_Homo sapiens_hsa00511 | 0.09085702 |
| 135 | Phototransduction_Homo sapiens_hsa04744 | 0.08251742 |
| 136 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.04608092 |
| 137 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.02185124 |
| 138 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0466133 |
| 139 | Pentose phosphate pathway_Homo sapiens_hsa00030 | -0.0415679 |
| 140 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0324781 |
| 141 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | -0.0248156 |

